肾素-血管紧张素系统
血管紧张素转换酶
血管紧张素II
医学
内科学
再灌注损伤
缺血
血管紧张素转化酶2
病理生理学
心脏病学
心功能曲线
心力衰竭
疾病
受体
血压
传染病(医学专业)
2019年冠状病毒病(COVID-19)
作者
Prabhat Kumar Upadhyay,Navneet Thakur,Vishal Kumar Vishwakarma,Hridaya Shankar Chaurasiya,Tarique Mahmood Ansari
标识
DOI:10.2174/0125899775280160240122065607
摘要
Abstract: The angiotensin-converting enzyme-2 (ACE-2) alters the pathophysiology of various fatal cardiovascular diseases, including ischemic heart disease, whereas angiotensin 1-7 (Ang 1–7) exerts a wide range of actions. The effects of ischemia-reperfusion (IR) injury include damage to myocardial tissue that initiates protease action, causing cardiac cell death. Angiotensin- II (Ang-II) contributes through the renin-angiotensin system (RAS) to the IR injury, whereas Ang 1–7 paradoxically exerts a protective effect through the same. Thus, the myocardial ischemic reperfusion injury (MIRI) may be altered by the RAS of the heart. This review paper focuses on ACE-2, angiotensin-converting enzyme (ACE), and Ang 1–7 regulation in the RAS of the heart in the pathophysiology of MIRI. The treatment in such conditions using ACE-2 activator, ACE inhibitor, and Ang-II antagonists may promote vascular functions as well as cardio- protection.
科研通智能强力驱动
Strongly Powered by AbleSci AI